Glenmark gets nod from Russian Ministry of Healthcare to market Montlezir film-coated tablets

30 Sep 2019 Evaluate

Glenmark Pharmaceuticals has received approval from the Ministry of Healthcare, Russia to market Montlezir (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film?coated tablets as a prescription product for the treatment of seasonal and perennial allergic rhinitis in patients above 15 years of age. Montlezir is expected to be available in the Russian market in Q3 FY 2019?20.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1949.50 -3.40 (-0.17%)
11-Dec-2025 13:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.85
Dr. Reddys Lab 1273.85
Cipla 1509.75
Zydus Lifesciences 924.50
Lupin 2080.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×